Targeting the Gut-Kidney Axis: Modulation of Gut Microbiota by Traditional Chinese Medicine for Chronic Kidney Disease Management. [PDF]
Xin Y, Pan L.
europepmc +1 more source
Chronic Periodontitis and Non-Alcoholic Fatty Liver Disease: Recent Advances in Mechanisms of Association. [PDF]
Lyu Z, Zhu J, Chen D.
europepmc +1 more source
Lower Thyroid Function and Higher Plasma Choline: Effect Modification by Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]
Post A +3 more
europepmc +1 more source
Gut microbiome and chemotherapy-induced cardiotoxicity: A systematic review of evidence and emerging therapies. [PDF]
Abdulaal R +10 more
europepmc +1 more source
Research Trends and Hotspots of Gut Microbiota and Its Metabolites in Cardiovascular Diseases: A Bibliometric Analysis. [PDF]
Zhang K +7 more
europepmc +1 more source
Etoxazole Exposure Triggers Sublethal Metabolic Responses in Earthworms (<i>Eisenia fetida</i>): An NMR-Based Metabolomics Study. [PDF]
Liao C +6 more
europepmc +1 more source
The Gut Microbiota-Metabolic Axis: Emerging Insights from Human and Experimental Studies on Type 2 Diabetes Mellitus-A Narrative Review. [PDF]
Alqahtani MS.
europepmc +1 more source
Gut Microbiota-Derived Metabolite and Heart Failure with Reduced Ejection Fraction (HFrEF): Elevated Trimethylamine N-Oxide (TMAO) as a Potential Biomarker. [PDF]
Kuan SW +5 more
europepmc +1 more source

